JAMES HEALY Insider Trading Transactions
Get free email notifications about insider trading for JAMES HEALY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES HEALY. JAMES HEALY is Director in AMARIN CORP PLC\UK ($AMRN) and Director in INTERMUNE INC ($ITMN) and Director in HYPERION THERAPEUTICS INC ($HPTX) and Director in Edge Therapeutics, Inc. ($EDGE) and Director in Coherus BioSciences, Inc. ($CHRS) and Director in Bolt Biotherapeutics, Inc. ($BOLT) and in Natera, Inc. ($NTRA) and Director in Natera, Inc. ($NTRA) and Director in Iterum Therapeutics plc ($ITRM) and Director in Y-mAbs Therapeutics, Inc. ($YMAB) and in Karuna Therapeutics, Inc. ($KRTX) and Director in Karuna Therapeutics, Inc. ($KRTX).
Latest Insider Trading Transactions of JAMES HEALY
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRN, BOLT, CHRS, HPTX, ITMN, ITRM, KRTX, NTRA, EDGE, YMAB
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | NTRA | Natera, Inc. | HEALY JAMES | Option Exercise | A | 94.14 | 2,614 | 246,082 | 2,614 | ||
Jun 02 2021 | NTRA | Natera, Inc. | HEALY JAMES | Option Exercise | A | 0.00 | 1,307 | 0 | 1,307 | ||
Jun 02 2021 | NTRA | Natera, Inc. | HEALY JAMES | Option Exercise | M | 0.00 | 2,856 | 0 | 0 | ||
Jun 02 2021 | NTRA | Natera, Inc. | HEALY JAMES | Buy | M | 0.00 | 2,856 | 0 | 32,472 | 29.6 K to 32.5 K (+9.64 %) | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,200,228 | 0 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,104,209 | 0 | 0 | |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | HEALY JAMES | Director | Buy | P | 20.00 | 450,000 | 9,000,000 | 2,754,437 | 2.3 M to 2.8 M (+19.53 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,200,228 | 0 | 2,304,437 | 1.1 M to 2.3 M (+108.70 %) |
Feb 09 2021 | BOLT | Bolt Biotherapeuti ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,104,209 | 0 | 1,104,209 | 0 to 1.1 M |
Jan 13 2021 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 17.58 | 20,000 | 351,600 | 20,000 | |
Oct 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 213,546 | 0 | 434,555 | 221 K to 434.6 K (+96.62 %) |
Oct 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | J | 0.00 | 950,000 | 0 | 0 | 950 K to 0 (-100.00 %) |
Oct 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 213,546 | 0 | 434,555 | 221 K to 434.6 K (+96.62 %) |
Oct 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | J | 0.00 | 950,000 | 0 | 0 | 950 K to 0 (-100.00 %) |
Sep 11 2020 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Director | Buy | P | 73.75 | 4,557 | 336,079 | 1,952,441 | 1.9 M to 2 M (+0.23 %) |
Sep 09 2020 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Director | Buy | P | 73.00 | 504 | 36,792 | 1,947,884 | 1.9 M to 1.9 M (+0.03 %) |
Sep 09 2020 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Director | Buy | P | 73.59 | 8,330 | 613,005 | 1,947,380 | 1.9 M to 1.9 M (+0.43 %) |
Sep 09 2020 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Director | Buy | P | 72.73 | 6,461 | 469,909 | 1,939,050 | 1.9 M to 1.9 M (+0.33 %) |
Sep 09 2020 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Director | Buy | P | 71.30 | 45,317 | 3,231,102 | 1,932,589 | 1.9 M to 1.9 M (+2.40 %) |
Sep 09 2020 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Director | Buy | P | 70.12 | 1,670 | 117,100 | 1,887,272 | 1.9 M to 1.9 M (+0.09 %) |
Sep 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 221,009 | 0 | 221,009 | 0 to 221 K |
Sep 01 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | J | 0.00 | 983,221 | 0 | 950,000 | 1.9 M to 950 K (-50.86 %) |
Jun 24 2020 | YMAB | Y-mAbs Therapeutic ... | HEALY JAMES | Director | Option Exercise | A | 48.67 | 16,000 | 778,720 | 16,000 | |
Jun 16 2020 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | A | 40.93 | 5,712 | 233,792 | 5,712 | |
Jun 16 2020 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | A | 0.00 | 2,856 | 0 | 2,856 | |
Jun 08 2020 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Option Exercise | A | 97.59 | 12,500 | 1,219,875 | 12,500 | ||
Jan 17 2020 | YMAB | Y-mAbs Therapeutic ... | HEALY JAMES | Director | Option Exercise | M | 21.45 | 8,000 | 171,600 | 8,000 | |
Jan 17 2020 | YMAB | Y-mAbs Therapeutic ... | HEALY JAMES | Director | Option Exercise | M | 11.16 | 17,778 | 198,402 | 14,222 | |
Jan 17 2020 | YMAB | Y-mAbs Therapeutic ... | HEALY JAMES | Director | Buy | M | 21.45 | 8,000 | 171,600 | 25,778 | 17.8 K to 25.8 K (+45.00 %) |
Jan 17 2020 | YMAB | Y-mAbs Therapeutic ... | HEALY JAMES | Director | Buy | M | 11.16 | 17,778 | 198,402 | 17,778 | 0 to 17.8 K |
Jan 14 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 17.73 | 20,000 | 354,600 | 20,000 | |
Jan 14 2020 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | M | 10.41 | 11,169 | 116,269 | 0 | |
Jan 14 2020 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | M | 11.80 | 11,169 | 131,794 | 0 | |
Jan 14 2020 | NTRA | Natera, Inc. | HEALY JAMES | Director | Buy | M | 10.41 | 11,169 | 116,269 | 29,616 | 18.4 K to 29.6 K (+60.55 %) |
Jan 14 2020 | NTRA | Natera, Inc. | HEALY JAMES | Director | Buy | M | 11.80 | 11,169 | 131,794 | 18,447 | 7.3 K to 18.4 K (+153.46 %) |
Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | M | 12.37 | 20,000 | 247,400 | 0 | |
Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | M | 10.05 | 20,000 | 201,000 | 0 | |
Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | M | 1.67 | 29,994 | 50,000 | 0 | |
Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | M | 12.37 | 20,000 | 247,400 | 70,086 | 50.1 K to 70.1 K (+39.93 %) |
Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | M | 10.05 | 20,000 | 201,000 | 50,086 | 30.1 K to 50.1 K (+66.48 %) |
Jan 13 2020 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | M | 1.67 | 29,994 | 50,000 | 30,086 | 92 to 30.1 K (+32,602.17 %) |
Nov 27 2019 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | M | 0.00 | 7,278 | 0 | 0 | |
Nov 27 2019 | NTRA | Natera, Inc. | HEALY JAMES | Director | Buy | M | 0.00 | 7,278 | 0 | 7,278 | 0 to 7.3 K |
Nov 25 2019 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Director | Buy | P | 96.00 | 156,250 | 15,000,000 | 1,885,602 | 1.7 M to 1.9 M (+9.04 %) |
Nov 25 2019 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Director | Buy | P | 96.00 | 156,250 | 15,000,000 | 1,885,602 | 1.7 M to 1.9 M (+9.04 %) |
Nov 01 2019 | YMAB | Y-mAbs Therapeutic ... | HEALY JAMES | Director | Buy | P | 28.00 | 90,000 | 2,520,000 | 2,194,278 | 2.1 M to 2.2 M (+4.28 %) |
Nov 01 2019 | YMAB | Y-mAbs Therapeutic ... | HEALY JAMES | Director | Buy | P | 28.00 | 90,000 | 2,520,000 | 2,194,278 | 2.1 M to 2.2 M (+4.28 %) |
Jul 02 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 22.61 | 160,000 | 3,617,600 | 1,933,221 | 2.1 M to 1.9 M (-7.64 %) |
Jul 02 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 22.05 | 200,000 | 4,410,000 | 2,093,221 | 2.3 M to 2.1 M (-8.72 %) |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 792,602 | 0 | 0 | |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Director | Buy | P | 16.00 | 700,000 | 11,200,000 | 1,729,352 | 1 M to 1.7 M (+68.00 %) |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,029,352 | 0 | 1,029,352 | 0 to 1 M |
Jul 01 2019 | KRTX | Karuna Therapeutic ... | HEALY JAMES | Director | Option Exercise | A | 16.00 | 32,500 | 520,000 | 32,500 | |
Jun 24 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 21.37 | 317,130 | 6,777,068 | 2,293,221 | 2.6 M to 2.3 M (-12.15 %) |
Jun 17 2019 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Option Exercise | A | 0.00 | 5,703 | 0 | 5,703 | |
Jun 14 2019 | YMAB | Y-mAbs Therapeutic ... | HEALY JAMES | Director | Option Exercise | A | 21.45 | 16,000 | 343,200 | 16,000 | |
May 29 2019 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | A | 22.83 | 22,000 | 502,260 | 22,000 | |
May 29 2019 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Option Exercise | M | 0.00 | 6,154 | 0 | 0 | |
May 29 2019 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Buy | M | 0.00 | 6,154 | 0 | 6,154 | 0 to 6.2 K |
May 24 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 20.69 | 257,870 | 5,335,330 | 2,610,351 | 2.9 M to 2.6 M (-8.99 %) |
Apr 16 2019 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | A | 0.00 | 7,278 | 0 | 7,278 | |
Jan 30 2019 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 12.37 | 20,000 | 247,400 | 20,000 | |
Sep 25 2018 | YMAB | Y-mAbs Therapeutic ... | HEALY JAMES | Director | Buy | P | 16.00 | 500,000 | 8,000,000 | 2,104,278 | 1.6 M to 2.1 M (+31.17 %) |
Sep 18 2018 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | A | 0.00 | 5,785 | 0 | 5,785 | |
Sep 18 2018 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | A | 24.42 | 11,169 | 272,747 | 11,169 | |
Aug 31 2018 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Sell | S | 20.50 | 25,000 | 512,500 | 2,868,221 | 2.9 M to 2.9 M (-0.86 %) |
May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 229,660 | 0 | 0 | |
May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 275,446 | 0 | 0 | |
May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 721,408 | 0 | 0 | |
May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Buy | P | 13.00 | 500,000 | 6,500,000 | 1,726,514 | 1.2 M to 1.7 M (+40.77 %) |
May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Buy | C | 0.00 | 229,660 | 0 | 1,226,514 | 996.9 K to 1.2 M (+23.04 %) |
May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Buy | C | 0.00 | 275,446 | 0 | 996,854 | 721.4 K to 996.9 K (+38.18 %) |
May 30 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Buy | C | 0.00 | 721,408 | 0 | 721,408 | 0 to 721.4 K |
May 29 2018 | ITRM | Iterum Therapeutic ... | HEALY JAMES | Director | Option Exercise | A | 0.00 | 6,154 | 0 | 6,154 | |
Feb 05 2018 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 10.05 | 20,000 | 201,000 | 20,000 | |
Jun 21 2017 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Option Exercise | A | 10.15 | 15,000 | 152,250 | 15,000 | |
Jun 13 2017 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | A | 10.41 | 11,169 | 116,269 | 11,169 | |
Jul 13 2016 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | A | 0.00 | 20,548 | 0 | 20,548 | |
Jul 13 2016 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | A | 2.19 | 28,847 | 63,175 | 28,847 | |
Jun 23 2016 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Option Exercise | A | 9.34 | 15,000 | 140,100 | 15,000 | |
Jun 14 2016 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | A | 11.80 | 11,169 | 131,794 | 11,169 | |
May 26 2016 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 18.28 | 10,000 | 182,800 | 10,000 | |
Mar 15 2016 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Buy | P | 7.30 | 541,343 | 3,951,641 | 2,852,711 | 2.3 M to 2.9 M (+23.42 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 2,473,118 | 0 | 0 | |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Buy | J | 8.60 | 53,665 | 461,519 | 2,311,368 | 2.3 M to 2.3 M (+2.38 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Buy | P | 11.00 | 450,000 | 4,950,000 | 2,257,703 | 1.8 M to 2.3 M (+24.89 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,807,703 | 0 | 1,807,703 | 0 to 1.8 M |
Jul 14 2015 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | A | 0.00 | 38,867,180 | 0 | 38,867,180 | |
Jul 09 2015 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,175,280 | 0 | 0 | |
Jul 09 2015 | NTRA | Natera, Inc. | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,175,280 | 0 | 0 | |
Jul 09 2015 | NTRA | Natera, Inc. | HEALY JAMES | Director | Buy | C | 0.00 | 1,175,280 | 0 | 1,550,280 | 375 K to 1.6 M (+313.41 %) |
Jul 09 2015 | NTRA | Natera, Inc. | HEALY JAMES | Director | Buy | P | 18.00 | 175,000 | 3,150,000 | 375,000 | 200 K to 375 K (+87.50 %) |
Jul 09 2015 | NTRA | Natera, Inc. | HEALY JAMES | Director | Buy | C | 0.00 | 1,175,280 | 0 | 1,550,280 | 375 K to 1.6 M (+313.41 %) |
Jul 09 2015 | NTRA | Natera, Inc. | HEALY JAMES | Director | Buy | P | 18.00 | 175,000 | 3,150,000 | 375,000 | 200 K to 375 K (+87.50 %) |
Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | A | 0.00 | 40,500 | 0 | 40,500 | |
Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | A | 2.50 | 23,144 | 57,860 | 23,144 | |
Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | HEALY JAMES | Director | Option Exercise | A | 2.50 | 17,358 | 43,395 | 17,358 | |
Jul 07 2015 | NTRA | Natera, Inc. | HEALY JAMES | Director | Buy | P | 22.81 | 200,000 | 4,561,900 | 200,000 | 0 to 200 K |
Jul 07 2015 | NTRA | Natera, Inc. | HEALY JAMES | Director | Buy | P | 22.81 | 200,000 | 4,561,900 | 200,000 | 0 to 200 K |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | D | 26.97 | 4,869 | 131,317 | 0 | |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | D | 24.46 | 9,800 | 239,708 | 0 | |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Option Exercise | D | 7.31 | 4,105 | 30,008 | 0 | |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Sell | U | 46.00 | 1,939,474 | 89,215,804 | 0 | 1.9 M to 0 (-100.00 %) |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Sell | D | 46.00 | 2,617 | 120,382 | 0 | 2.6 K to 0 (-100.00 %) |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Sell | U | 46.00 | 5,006 | 230,276 | 0 | 5 K to 0 (-100.00 %) |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Gift | G | 0.00 | 327 | 0 | 5,006 | 5.3 K to 5 K (-6.13 %) |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Gift | G | 0.00 | 1,087 | 0 | 5,333 | 6.4 K to 5.3 K (-16.93 %) |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Gift | G | 0.00 | 1,087 | 0 | 6,420 | 7.5 K to 6.4 K (-14.48 %) |
May 08 2015 | HPTX | HYPERION THERAPEUT ... | HEALY JAMES | Director | Gift | G | 0.00 | 4,348 | 0 | 7,507 | 11.9 K to 7.5 K (-36.68 %) |
Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 29.00 | 25,000 | 725,000 | 25,000 | |
Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 | |
Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 239,364 | 0 | 2,893,221 | 2.7 M to 2.9 M (+9.02 %) |
Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 96,098 | 0 | 2,653,857 | 2.6 M to 2.7 M (+3.76 %) |
Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 33 | 0 | 92 | 59 to 92 (+55.93 %) |
Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 12 | 0 | 59 | 47 to 59 (+25.53 %) |
Jun 03 2013 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | A | 9.99 | 6,000 | 59,940 | 6,000 | |
Jun 03 2013 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Jun 06 2012 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | A | 10.10 | 6,000 | 60,600 | 6,000 | |
Jun 06 2012 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Grant | A | 10.10 | 2,500 | 25,250 | 9,150 | 6.7 K to 9.2 K (+37.59 %) |
May 12 2011 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | A | 39.46 | 12,000 | 473,520 | 12,000 | |
Jan 03 2011 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Gift | G | 0.00 | 2,499 | 0 | 4,150 | 6.6 K to 4.2 K (-37.58 %) |
May 10 2010 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | A | 10.37 | 12,000 | 124,440 | 187,393 | |
Jan 27 2010 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | M | 4.50 | 5,000 | 22,500 | 0 | |
Jan 27 2010 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Buy | M | 4.50 | 5,000 | 22,500 | 6,649 | 1.6 K to 6.6 K (+303.21 %) |
Jun 24 2009 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | A | 11.33 | 12,000 | 135,960 | 188,393 | |
May 15 2008 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | A | 15.34 | 12,000 | 184,080 | 168,393 | |
May 17 2007 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | A | 25.55 | 12,000 | 306,600 | 156,393 | |
May 25 2006 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | A | 14.41 | 20,000 | 288,200 | 144,393 | |
Mar 03 2006 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Sell | S | 19.27 | 7,541 | 145,305 | 1,649 | 9.2 K to 1.6 K (-82.06 %) |
Mar 03 2006 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Sell | S | 19.61 | 10,000 | 196,050 | 9,190 | 19.2 K to 9.2 K (-52.11 %) |
Feb 24 2006 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Sell | S | 19.10 | 5,000 | 95,500 | 19,190 | 24.2 K to 19.2 K (-20.67 %) |
Feb 23 2006 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Sell | S | 19.05 | 5,000 | 95,250 | 24,190 | 29.2 K to 24.2 K (-17.13 %) |
Feb 23 2006 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Sell | S | 18.80 | 10,000 | 188,000 | 29,190 | 39.2 K to 29.2 K (-25.52 %) |
Nov 16 2005 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Gift | G | 0.00 | 2,000 | 0 | 75,132 | 77.1 K to 75.1 K (-2.59 %) |
May 31 2005 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | A | 11.95 | 20,000 | 239,000 | 138,335 | |
Jan 04 2005 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | A | 13.26 | 8,335 | 110,522 | 8,335 | |
Jan 05 2004 | ITMN | INTERMUNE INC | HEALY JAMES | Director | Option Exercise | A | 23.16 | 25,000 | 579,000 | 25,000 |
Page: 1